Skye Bioscience, Inc. — All Filings
587 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
PRE 14C
PREM14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-3 | S-3 | 0001628280-24-022632 | May 10, 2024 | — |
| 10-Q | 10-Q | 0001516551-24-000055 | May 10, 2024 | Mar 31, 2024 |
| EFFECT | — | 9999999995-24-001154 | Apr 26, 2024 | — |
| POS AM | POS AM | 0001628280-24-017677 | Apr 24, 2024 | — |
| 8-A12B | 8-A12B | 0001628280-24-015551 | Apr 10, 2024 | — |
| CERT | — | 0001354457-24-000263 | Apr 10, 2024 | — |
| 424B3 | 424B3 | 0001628280-24-015630 | Apr 10, 2024 | — |
| EFFECT | — | 9999999995-24-000923 | Apr 10, 2024 | — |
| CORRESP | — | 0001628280-24-015500 | Apr 9, 2024 | — |
| CORRESP | — | 0001628280-24-015401 | Apr 9, 2024 | — |
| CORRESP | — | 0001628280-24-015480 | Apr 9, 2024 | — |
| S-1/A | S-1/A | 0001628280-24-014904 | Apr 4, 2024 | — |
| 8-K | 8-K | 0001516551-24-000052 | Apr 3, 2024 | — |
| UPLOAD | — | 0000000000-24-003511 | Apr 2, 2024 | — |
| S-1 | S-1 | 0001628280-24-013372 | Mar 27, 2024 | — |
| D | — | 0000925421-24-000004 | Mar 27, 2024 | — |
| 10-K | FORM 10-K | 0001516551-24-000048 | Mar 22, 2024 | Dec 31, 2023 |
| 4 | — | 0001415889-24-008107 | Mar 15, 2024 | Mar 13, 2024 |
| 4 | — | 0001415889-24-008106 | Mar 15, 2024 | Mar 13, 2024 |
| 8-K | 8-K | 0001516551-24-000045 | Mar 13, 2024 | Mar 11, 2024 |
| SC 13D/A | SC 13D/A | 0001104659-24-034066 | Mar 13, 2024 | — |
| 4 | FORM 4 | 0001516551-24-000038 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000039 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000043 | Mar 4, 2024 | Feb 29, 2024 |
| 8-K | 8-K | 0001516551-24-000034 | Mar 4, 2024 | Feb 29, 2024 |
| 4/A | FORM 4/A | 0001516551-24-000014 | Mar 4, 2024 | Feb 29, 2024 |
| 4/A | FORM 4/A | 0001516551-24-000016 | Mar 4, 2024 | Feb 29, 2024 |
| 3 | FORM 3 | 0001516551-24-000032 | Mar 4, 2024 | Feb 29, 2024 |
| 3 | FORM 3 | 0001516551-24-000018 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000020 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000022 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000025 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000027 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000030 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000010 | Mar 1, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001516551-24-000012 | Mar 1, 2024 | Feb 29, 2024 |
| D | — | 0001516551-24-000003 | Feb 12, 2024 | — |
| 8-K | 8-K | 0001516551-24-000008 | Feb 12, 2024 | — |
| SC 13G | SC 13G | 0001178913-24-000414 | Feb 8, 2024 | — |
| SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001999371-24-001474 | Feb 5, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-24-002649 | Feb 2, 2024 | Jan 31, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-002643 | Feb 2, 2024 | Jan 31, 2024 |
| SC 13D/A | SC 13D/A | 0001104659-24-008803 | Jan 31, 2024 | — |
| 8-K | 8-K | 0001516551-24-000002 | Jan 29, 2024 | — |
| S-8 | S-8 | 0001516551-23-000107 | Dec 22, 2023 | — |
| 8-K | 8-K | 0001516551-23-000103 | Dec 5, 2023 | Nov 29, 2023 |
| 10-Q | 10-Q | 0001516551-23-000100 | Nov 14, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0001516551-23-000083 | Nov 7, 2023 | Nov 6, 2023 |
| 4 | FORM 4 | 0001516551-23-000098 | Nov 6, 2023 | — |
| 4 | FORM 4 | 0001516551-23-000097 | Nov 6, 2023 | — |